Related Experiment Videos

Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1

M A Navia1, P M Fitzgerald, B M McKeever

  • 1Department of Biophysical Chemistry, Merck Sharp and Dohme Research Laboratories, Rahway, New Jersey 07065.

Nature
|February 16, 1989
PubMed

Insights

The crystal structure of human immunodeficiency virus type 1 (HIV-1) protease was determined. This enzyme is crucial for viral maturation and shares structural similarities with microbial aspartyl proteases.

Area of Science:

  • Structural biology
  • Virology
  • Biochemistry

Background:

  • Human immunodeficiency virus type 1 (HIV-1) protease is essential for viral replication.
  • Protease activity releases functional viral proteins from polyprotein precursors.
  • Understanding HIV-1 protease structure is key to developing antiviral therapies.

Purpose of the Study:

  • To determine the high-resolution crystal structure of the HIV-1 protease dimer.
  • To elucidate the structural basis for protease function and its relationship to other aspartyl proteases.
  • To investigate the mechanism of protease autoproteolytic release and its role in virus maturation.

Main Methods:

  • X-ray crystallography was used to determine the crystal structure.
  • The structure was resolved to 3 Angstrom resolution.
  • Comparative structural analysis was performed with microbial aspartyl proteases.

Main Results:

  • The crystal structure of the HIV-1 protease dimer was successfully determined.
  • Significant structural homology was observed between the HIV-1 protease active site and microbial aspartyl proteases.
  • The determined structure provides insights into the autoproteolytic release mechanism of the protease.

Conclusions:

  • The structural data reveals conserved features with microbial aspartyl proteases, suggesting a common evolutionary origin.
  • The structure offers a mechanistic understanding of how HIV-1 protease is released and regulates virus maturation.
  • This structural information can guide the design of novel HIV-1 protease inhibitors.

Related Concept Videos